CP1 0.00% 17.0¢ cannpal animal therapeutics limited

Ann: Quarterly Report 30 June 2019, page-15

  1. 6,233 Posts.
    lightbulb Created with Sketch. 97
    no real news to speak of for months, but plenty going on, holding a few now in anticipation of the newsflow to begin. cheap stock for what they are doing. once it gets attention should really fly with such thin volumes and low SOI. 2 phase 2 trials and the CSIRO encapsulation tech, which has been used by companies like PET and CLV could easily be a quick 200% in it just looking at PAA.
 
watchlist Created with Sketch. Add CP1 (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.